Please click here to view the 2019 Journal of Drug Assessment.
To view abstract posters, please click on the abstract titles below.
patiromer and maintenance of RAASi Therapy in Hyperkalemic Medicare Patients
Authors: Desai NR, Rowan CG, Alvarez PJ, FOgl
Psoriasis Patients utilizing secukinumab, ixekizumab or brodalumab – comparisons to prior biologic medication adherence levels, reasons for switching, and reported changes in disease symptoms
Authors: Baiano R, Staskon F, Miller R
The impact of an integrated health-system specialty pharmacy on HIV antiretrovial therapy adherence, viral suppression and CD4 Count in an Outpatient ID clinic
Authors: Barnes E, Giumenta A, Johnson M, Zhao J
Assess integrated specialty pharmacy services as a medication optimization strategy for rifaximin in hepatic encephalopathy patients
Authors: Mac E, Battershell A, Buaisha H, Nolan K
Medication adherence and graft survival among heart transplant recipients
Author: Boghani S, Kirkham H, Witt EA, Hira N, Cherikh WS, Wilk AR, Maghirang J, Pietradoni G
Medication adherence and graft survival among kidney transplant recipients
Author: Boghani S, Kirkham H, Witt EA, Hira N, Cherikh WS, Wilk AR, Maghirang J, Pietradoni G
Management of specialty drugs, specialty pharmacies, and biosimilars in the united states
Authors: Brook R, Smeeding J, Carlisle J, Sax M
United States Health plan cancer concerns in 2019
Authors: Brook R, Sax M, Carlisle J, Smeeding J
Adherence of patients to oral oncolytic and neurologic specialty medications provided by a specialty pharmacy
Authors: Bhusal B, Oleru K, Arikian V, Jaster R, Stranz M, Lindhorst J
Appropriate prescribing of antimetics with oral oncolytic therapy – a single center experience
Authors: Suen CT, Hughes ME, Timlin C, Cambareri C, Kriska R, Strong G, Favatella JK, Demers R, Capozzi DL
Variation in health plan specialty drug coverage: An empirical analysis
Authors: Margaretos NM, Lai RC, Panzer AD, Chambers JD
Development of a collaborative pharmacy practice agreement to improve efficiency and management of prescribing in a renal transplant clinic
Authors: Chelewski R, Johnson K, Suckerman A, DeClercq J, Choi L, Peter M, Langone A
Hereditary angioedema C1-inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
Authors: Farkas H, Fridman M, Supina D, Chiao J, Prusty S, Berger M
Coupling patient care management operations with technology and data platform to optimize hepatitis C therapy outcomes
Authors: Duong L, Malachowski M, Tran K
Clinical impact of a pharmacist interventions on improving outcomes in patients receiving immune globulin therapy in a home setting
Authors: DiStefano J, Vaughan L
Determining Specialty pharmacy FTEs (Full-Time equivalents) needed in a clinical practice
Authors: Holton J, Favatella J, Capozzi D, Demers R
Real-World assessment of an integrated clinical model on oral hepatitis C therapy at Southern ohio medical center
Authors: Ferraro R, Quillen S, Phillips R, Newman B
Impact of ambulatory clinical pharmacists interventions on outcomes in the HIV population
Authors: Foltanski L
Development of a palivizumab specialty pharmacy management program
Authors: Harlan L, Benskin K, Gatzke C, Majors A
Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
Authors: Tyson C, Anurag R, Adams P, Haynes A, Magar R
Cost of leukopenia and neutropenia in metastatic breast cancer within last 12, 36, and 60 months using a curated disease model
Authors: Alford SH, Ng M, Meade M
Integrating high touch specialty pharmacy services within a neurology clinic to improve medication access and affordability
Author: Hickman A, Edwards K
Implementation of an Internal Check of Oral Oncolytics: A single-center, specialty pharmacy safety initiative
Author: Hughes M, Kriska R, Strong G, Chung J, Nguyen L, Rubin D, Murphy M, Favatella J, Capozzi D
Impact of specialty pharmacy taking ownership of the prior authorization process of Multiple sclerosis specialty medications to increase access to infusible disease-modifying therapy (DMT)
Authors: Whetstone M, Reichard J, Sigmon S
Impact of a specialty pharmacy benefit on rheumatoid arthritis medication adherence and functional status: a continuation study
Authors: Zande M, Wickizer M, Topp R, Faust S, Hustad C
Economic burden of hemophilia B in the US: A systematic literature review
Authors: Li N, Sawyer EK, Maruszczyk K, Slomka M, Burke T, Martin AP, O’Hara J
Impact of specialty pharmacist integration on time to medication access for pimavanserin
Authors: Livezey S, McCormick R, Shah NB, Choi L, DeClercq J, Zuckerman AD
A targeted approach to reducing rates of discontinuation and dose reduction in patients receiving sorafenib or regorafenib
Authors: Nix R, Looney B, Lamb C, Peter M, Zuckerman AD
Measuring the impact of integrating PGY-2 ambulatory care pharmacy residents into specialty clinics
Authors: Spencer C, Woosley M, Brenske A, O’Reilly E.
Comparison of Extended to standard half-life recombinant factor VII therapy in patients with hemophilia A on Prophylactic treatment
Authors: Koerner P, Miller R, Radi M
impact of using real – world outcomes versus clinical evidence and list prices on value assessments
Authors: Meade D, Ng M, Alford SH
Understanding purchasing patterns and product access of newly launched specialty generics
Authors: Ness S, Lucas R
Development of a specialty pharmacy productivity benchmarking model
Authors: Platt T, Shah R
Estimating the value of pharmacist interventions in a specialty pharmacy setting
Authors: Craig R, Grant K
Evaluation of a specialty pharmacy health coaching program
Authors: Simonson D, Wittenborg M, Snyder M, Wiest H, McNamara A
Impact of multidisciplinary patient education sessions on expectations and understanding of new CGRP treatments
Authors: Stewart A, Wells R, Young J, Strauss L, Wise S, Granetzke L, Kumar S, Speiser J, Guzik A, O’Connell N
Impact of outpatient specialty pharmacy on medication adherence in post-kidney transplant patients
Authors: Petrosan A, Belfield K, Cohen E, DelVecchio M, Stutsky M
Impact of health-system specialty pharmacy services on medication adherence in pediatric patients with cystic fibrosis
Authors: Tao V, Papiro T, Stutsky M, DelVecchio M, Kelly SA
Correlates and barriers to medication adherence in multiple sclerosis patients and their impact on clinical outcomes
Authors: McPherson D, D’Ambrosi M, Stutsky M
A novel tool to monitor adherence to oral oncolytics: a pilot study
Authors: Sun W, Reeve R, Ouellette T, Stutsky M, De Jesus R, Huffer MJ, Mougalian SS
Patterns of on-demand medication use in patients with hereditary angioedema treated long-term with prophlactic subcutaneous C1-inhibitor
Authors: Levy DS, Chiao J, Dang J, Hood C, Supina D, Feuersenger H
Comparison of healthcare utilization among managed Medicaid individuals diagnosed with multiple sclerosis treated with emergent vs. established disease modifying therapy
Authors: Sutton B, Petrilla A, Teigland C
Impact of a high-touch, collaborative, patient-centric, hepatitis C specialty clinical program on completion of glecaprevir/pibrentasvir therapy
Authors: Swoope M, Bertram C, Krouskos R, Peeler G, Wood C
Predicting Time to Medication Access for Hematologic Malignancies: The impact of an integrated specialty pharmacy and limited distribution drug networks
Authors: Zuckerman AD, Peter ME, Starks S, Maulis M, Declerq J, Choi L, Jagasia M